Jones William A JR
SEC-identified person · CIK 1373097 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Annexon, Inc. ANNX | Director | filed 2025 - 2026 |
| Apogee Therapeutics, Inc. APGE | Director | filed 2023 - 2026 |
| Newamsterdam Pharma Co N.V. NAMS | Chief Commercial Officer | filed 2024 - 2025 |
| Social Capital Suvretta Holdings Corp. I DNAA | Director | filed 2022 - 2023 |
| Biohaven Pharmaceutical Holding Co Ltd. BHVN | CCO-Migraine & Common Disease | filed 2019 - 2022 |
| Nitromed INC NTMD | Vice President | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.